Evaluate Efficacy, and Safety of Topical Therapy and Etanercept in Subjects With Moderate to Severe Plaque Psoriasis
Clinical trial NCT01235442 · COMPLETED
Trial details
- NCT number
- NCT01235442
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2011-10-01
- Enrollment
- 592
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.